-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.3376.11% Upside
DiaMedica Therapeutics Inc. Frequently Asked Questions
-
What analysts cover DiaMedica Therapeutics Inc.?
DiaMedica Therapeutics Inc. has been rated by research analysts at Truist Financial, H.C. Wainwright, Craig-Hallum in the past 90 days.